Table 4 Baseline characteristics between the sustained responder and non-sustained responder in eradicated group.
From: Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia
Sustained response | Non-sustained response | P-value | |||
|---|---|---|---|---|---|
N | Mean ± SD | N | Mean ± SD | ||
Age (year) | 10 | 50.4 ± 9.0 | 15 | 54.5 ± 14.3 | 0.434 |
Sex (male) | 3 | 37.5% | 5 | 62.5% | 0.741 |
Platelet, ×103/dL | 10 | 61.6 ± 24.6 | 15 | 43.2 ± 21.1 | 0.058 |
MPV, fL | 9 | 11.5 ± 2.9 | 12 | 10.5 ± 1.3 | 0.287 |
WBC, ×103/dL | 10 | 8.2 ± 2.2 | 15 | 7.7 ± 3.1 | 0.727 |
Neutrophil, ×103/dL | 10 | 5.6 ± 2.1 | 15 | 4.7 ± 2.3 | 0.344 |
Lymphocyte, ×103/dL | 10 | 2.1 ± 0.9 | 15 | 2.4 ± 1.2 | 0.536 |
Monocyte, ×103/dL | 10 | 0.4 ± 0.2 | 15 | 0.4 ± 0.2 | 0.859 |
Eosinophil, ×103/dL | 10 | 0.1 ± 0.1 | 15 | 0.3 ± 0.5 | 0.309 |
Basophil, ×103/dL | 10 | 0.0 ± 0.0 | 15 | 0.0 ± 0.0 | 0.518 |
Hemoglobin, g/dL | 10 | 13.4 ± 1.8 | 15 | 12.3 ± 3.2 | 0.318 |
Reticulocyte, g/dL | 5 | 76.3 ± 22.1 | 9 | 69.4 ± 32.7 | 0.685 |
NLR | 10 | 3.4 ± 4.2 | 15 | 1.8 ± 0.8 | 0.256 |
CRP, mg/dL | 6 | 0.1 ± 0.1 | 7 | 1.3 ± 2.0 | 0.148 |
ESR, mm/hr | 4 | 11.0 ± 6.1 | 6 | 33.2 ± 30.8 | 0.201 |
Antinuclear antibody positivity | 0 | 0.0% | 2 | 100.0% | 0.097 |
Treatment response at 2 months | |||||
Complete response | 7 | 77.8% | 2 | 22.2% | 0.010 |
Response | 1 | 50.0% | 1 | 50.0% | |
No response | 2 | 14.3% | 12 | 85.7% | |
